TEMPORAL MUSCLE THICKNESS AS A PROGNOSTIC MARKER IN A REAL-LIFE COHORT OF NEWLY DIAGNOSED MGMT PROMOTER METHYLATED GLIOBLASTOMA PATIENTS: A MULTICENTRIC IMAGING ANALYSIS

被引：0

作者：

Lazaridis, Lazaros ^{[1
,2
]}

Moenninghoff, Christoph ^{[3
]}

Bumes, Elisabeth ^{[4
]}

Spille, Dorothee Caecilia ^{[5
]}

Muether, Michael ^{[5
]}

Schulz, Tim ^{[6
]}

Heider, Sina ^{[7
]}

Agkatsev, Sarina ^{[1
,2
]}

Schmidt, Teresa

Blau, Tobias ^{[8
]}

Oster, Christoph

Stummer, Walter ^{[1
,2
,5
]}

Kessler, Almuth Friederike ^{[6
]}

Seidel, Clemens ^{[7
]}

Grauer, Oliver ^{[9
]}

Hau, Peter ^{[4
,10
]}

Sure, Ulrich ^{[11
]}

Keyvani, Kathy

Herrlinger, Ulrich ^{[12
,13
]}

Kleinschnitz, Christoph

Stuschke, Martin ^{[14
]}

Herrmann, Ken ^{[15
]}

Deuschl, Cornelius ^{[16
]}

Scheffler, Bjoern ^{[17
]}

Kebir, Sied ^{[1
,2
]}

Glas, Martin ^{[1
,2
]}

机构：

[1] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany

[2] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[3] Johannes Wesling Klinikum Minden, Univ Inst Radiol Neuroradiol & Nucl Med, Minden, Germany

[4] Regensburg Univ Hosp, Wilhelm Sander Neurooncol Unit, Regensburg, Germany

[5] Univ Hosp Munster, Dept Neurosurg, Munster, Germany

[6] Univ Hosp Wurzburg, Dept Neurosurg, Wurzburg, Germany

[7] Univ Hosp Leipzig, Dept Radiotherapy & Radiat Oncol, Leipzig, Germany

[8] Univ Duisburg Essen, Univ Med Essen, Inst Neuropathol, Essen, Germany

[9] Univ Hosp Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany

[10] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany

[11] Univ Duisburg Essen, Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany

[12] Univ Hosp Bonn, Div Clin Neurooncol, Dept Neurol, Bonn, Germany

[13] Univ Hosp Bonn, Ctr Integrated Oncol, Bonn, Germany

[14] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany

[15] Univ Duisburg Essen, Univ Med Essen, Dept Nucl Med, Essen, Germany

[16] Univ Duisburg Essen, Univ Med Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany

[17] German Canc Res Ctr, Heidelberg, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-34

引用

页数：2

共 50 条

[1] TEMPORAL MUSCLE THICKNESS AS A PROGNOSTIC MARKER IN A REAL-LIFE COHORT OF NEWLY DIAGNOSED MGMT PROMOTER METHYLATED GLIOBLASTOMA PATIENTS: A MULTICENTRIC IMAGING ANALYSIS
Lazaridis, L.
Moenninghoff, C.
Schmidt, T.
Agkatsev, S.
Blau, T.
Spille, D.
Heider, S.
Schulz, T.
Bumes, E.
Oster, C.
Stummer, W.
Kessler, A.
Seidel, C.
Hau, P.
Sure, U.
Keyvani, K.
Herrlinger, U.
Grauer, O.
Kleinschnitz, C.
Stuschke, M.
Herrmann, K.
Deuschl, C.
Scheffler, B.
Kebir, S.
Glas, M.
NEURO-ONCOLOGY, 2023, 25
[2] FIRST MULTICENTRIC REAL-LIFE EXPERIENCE WITH THE COMBINATION OF LOMUSTINE AND TEMOZOLOMIDE IN NEWLY DIAGNOSED MGMT PROMOTER METHYLATED IDH WILDTYPE GLIOBLASTOMA
Lazaridis, L.
Schmidt, T.
Agkatsev, S.
Blau, T.
Spille, D.
Heider, S.
Schulz, T.
Bumes, E.
Oster, C.
Feldheim, J.
Stummer, W.
Kessler, A.
Seidel, C.
Hau, P.
Sure, U.
Keyvani, K.
Herrlinger, U.
Kleinschnitz, C.
Stuschke, M.
Herrmann, K.
Deuschl, C.
Hattingen, E.
Scheffler, B.
Kebir, S.
Glas, M.
NEURO-ONCOLOGY, 2022, 24
[3] FIRST MULTICENTRIC REAL-LIFE EXPERIENCE WITH THE COMBINATION OF CCNU AND TEMOZOLOMIDE IN NEWLY DIAGNOSED MGMT PROMOTER METHYLATED IDH WILDTYPE GLIOBLASTOMA
Lazaridis, Lazaros
Bumes, Elisabeth
Spille, Dorothee Cacilia
Schulz, Tim
Heider, Sina
Agkatsev, Sarina
Schmidt, Teresa
Blau, Tobias
Oster, Christoph
Feldheim, Jonas
Stummer, Walter
Kessler, Almuth Friederike
Seidel, Clemens
Grauer, Oliver
Hau, Peter
Sure, Ulrich
Keyvani, Kathy
Herrlinger, Ulrich
Kleinschnitz, Christoph
Stuschke, Martin
Herrmann, Ken
Deuschl, Cornelius
Breuer, Stella
Hattingen, Elke
Scheffler, Bjoern
Kebir, Sied
Glas, Martin
NEURO-ONCOLOGY, 2022, 24 : 74 - 74
[4] First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
Lazaridis, Lazaros
Bumes, Elisabeth
Spille, Dorothee Caecilia
Schulz, Tim
Heider, Sina
Agkatsev, Sarina
Schmidt, Teresa
Blau, Tobias
Oster, Christoph
Feldheim, Jonas
Stummer, Walter
Kessler, Almuth Friederike
Seidel, Clemens
Grauer, Oliver
Hau, Peter
Sure, Ulrich
Keyvani, Kathy
Herrlinger, Ulrich
Kleinschnitz, Christoph
Stuschke, Martin
Herrmann, Ken
Deuschl, Cornelius
Breuer, Stella
Hattingen, Elke
Scheffler, Bjoern
Kebir, Sied
Glas, Martin
NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
[5] Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study
Broen, Martinus P. G.
Beckers, Rueben
Willemsen, Anna C. H.
Huijs, Sandra M. H.
Pasmans, Raphael C. O. S.
Eekers, Danielle B. P.
Ackermans, Linda
Beckervordersandforth, Jan
van Raak, Elisabeth P. M.
Verduin, Maikel
Anten, Monique H. M. E.
Hoeben, Ann
Postma, Alida A.
NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
[6] Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials
Furtner, Julia
Weller, Michael
Weber, Michael
Gorlia, Thierry
Nabors, Burt
Reardon, David A.
Tonn, Joerg C.
Stupp, Roger
Preusser, Matthias
CLINICAL CANCER RESEARCH, 2022, 28 (01) : 129 - 136
[7] Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Furtner, Julia
Berghoff, Anna S.
Schoepf, Veronika
Reumann, Robert
Pascher, Benjamin
Woitek, Ramona
Asenbaum, Ulrika
Pelster, Sebastian
Leitner, Johannes
Widhalm, Georg
Gatterbauer, Brigitte
Dieckmann, Karin
Hoeller, Christoph
Prayer, Daniela
Preusserz, Matthias
JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 173 - 178
[8] Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Julia Furtner
Anna S. Berghoff
Veronika Schöpf
Robert Reumann
Benjamin Pascher
Ramona Woitek
Ulrika Asenbaum
Sebastian Pelster
Johannes Leitner
Georg Widhalm
Brigitte Gatterbauer
Karin Dieckmann
Christoph Höller
Daniela Prayer
Matthias Preusser
Journal of Neuro-Oncology, 2018, 140 : 173 - 178
[9] The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
Villani, Veronica
Casini, Beatrice
Pace, Andrea
Prosperini, Luca
Carapella, Carmine M.
Vidiri, Antonello
Fabi, Alessandra
Carosi, Andmariantonia
DISEASE MARKERS, 2015, 2015
[10] Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
Flies, Christina Maria
Friedrich, Michel
Lohmann, Philipp
van Garderen, Karin Alida
Smits, Marion
Tonn, Joerg-Christian
Weller, Michael
Galldiks, Norbert
Snijders, Tom Jan
NEURO-ONCOLOGY, 2024, 26 (05) : 902 - 910

← 1 2 3 4 5 →